pharm-contract-packaging-995x60 pharm-contract-packaging-995x60




  • The Role Of Pharmaceutical Packaging Partners In Times Of Growth

    The expanding global pharmaceutical industry projects a 4%-6% annual growth and forecasts that it will reach a value of $1T by 2014. By Paul Dupont

  • Four Reasons For The Rise In Blister Packaging

    Blister packaging, not long ago considered a less significant segment of the North American pharmaceutical packaging industry, is now outpacing most other industry segments. In 2010, blister represented 17% of the global market and recorded $8.1B in revenue, according to Pharmaceutical Packaging Industry – 2011 Yearbook. GBI Research. By Paul Dupont, Director of Business Development North America, Ropack, Inc.

  • How To Survive An FDA Audit

    Audits by the Food and Drug Administration (FDA), historically a source of angst, may be generating even more concern. Recently, the FDA has escalated its cGMP compliance inspections by enforcing increasingly complex regulations, gaining greater access to records and conducting audits more frequently – up from .06 to .09 per year, according to Bloomberg News. By Paul Dupont, Ropack

  • Benefits Of Blister Packaging For Emerging Markets

    Global research on the pharmaceutical packaging market indicates that blister packaging will continue its robust growth, projected through the remaining decade to trail bottling only slightly in market share. While mature markets, such as Europe and Asia, already accept blister packs as a preferred method – and with North America stepping up its blister usage – these markets, surprisingly, are not the driving force in blister’s growth. Instead, the increase is expected, in large part, to be spurred by the benefits blister packaging brings to emerging markets where product protection, patient compliance and the need for daily or weekly prescription dosage are often primary considerations. By Paul Dupont

  • Drug Safety And Product Protection Driving Blister Packaging Growth

    Trends in packaging of prescription and over-the-counter drugs indicate continued growth in the blister packaging market. The U.S. blister market size reached $2.58 billion in 2013 and is projected to reach $3.44 billion by 2018. This escalation outpaces the growth of other packaging formats, principally bottling. While key factors driving that trend reflect the ongoing focus by manufacturers on drug safety and protection, others arise from the latest government regulations and the growing voice of the consumer.

  • The Preferred Packaging Option - Stick Packaging

    Stickpack packaging in single-dose is globally accepted for its accuracy, convenience, and cost savings. These slim, sealed, tube-shaped packets — approximately the size of a stick of gum — are a preferred packaging design among European and Japanese consumers for the convenience, flexibility, and portability their active lives demand. By Ropack, Inc.

More From Pharmaceutical Contract Packaging


Unit Dose Contract Packaging For Pediatric Dosage Forms

Unit Dose Contract Packaging For Pediatric Dosage Forms

Easily blended in a child’s food or beverage, pediatric powders in unit-dose stick-packs provide taste masking and convenience without compromising integrity.

Pharmaceutical Contract Packaging: Primary And Secondary Packaging Services

Pharmaceutical Contract Packaging: Primary And Secondary Packaging Services

Ropack offers turnkey contract primary and secondary pharmaceutical packaging services of solid oral dosages, tablets, powder, and encapsulation into blisters, pouches, stick-packs, bottles, and carded blisters.

Pharmaceutical Contract Packaging Technology

Pharmaceutical Contract Packaging Technology

HVAC Ventilation and AC Systems

More Products & Services
Newsletter Signup
Newsletter Signup
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.